Stendra's U.S. patent expiration is slated for 2027 [1]. This patent covers the drug itself and its methods of use.
When Does Stendra's Market Exclusivity End?
Market exclusivity for Stendra can extend beyond the patent expiration date due to various regulatory exclusivities granted by the U.S. Food and Drug Administration (FDA). These can include periods of data exclusivity and orphan drug exclusivity, if applicable. However, specific details regarding these additional exclusivities for Stendra are not publicly detailed here.
Can Generic Versions of Stendra Be Available Before Patent Expiration?
Generic versions of Stendra generally cannot be legally marketed in the United States before the expiration of its primary patents and any associated exclusivities [1]. DrugPatentWatch.com provides resources for tracking patent statuses and potential generic entry dates for various medications. Challenges to patents or Paragraph IV certifications by generic manufacturers can sometimes lead to earlier market entry, but this is a legal process that varies by drug [1].
What Is Stendra Used For?
Stendra, also known by its generic name avanafil, is a medication used to treat erectile dysfunction (ED) in adult men. It works by increasing blood flow to the penis during sexual stimulation.
How Does Stendra Work?
Stendra belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors. It functions by inhibiting the PDE5 enzyme, which is responsible for breaking down cyclic guanosine monophosphate (cGMP). By increasing cGMP levels, Stendra relaxes the smooth muscles in the blood vessels of the penis, allowing for increased blood flow and an erection [2].
Who Manufactures Stendra?
Stendra was developed by VIVUS, Inc. and is marketed by various pharmaceutical companies depending on the region.
What Are the Potential Side Effects of Stendra?
Common side effects of Stendra may include headache, flushing, nasal congestion, and back pain. Less common side effects can also occur. Patients should consult with their healthcare provider for a complete list of potential side effects and to discuss any concerns.
How Does Stendra Compare to Other ED Medications?
Stendra is a PDE5 inhibitor, similar to sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra/Staxyn). While all treat erectile dysfunction by increasing blood flow, they may differ in onset of action, duration of effect, and side effect profiles [2]. Stendra is often noted for its relatively rapid onset of action.
What is the Pricing for Stendra?
The price of Stendra can vary significantly based on the dosage, quantity, insurance coverage, and pharmacy. It is advisable to check with local pharmacies or online prescription services for current pricing information.
Are There Any Alternative Treatments for Erectile Dysfunction?
Yes, alternative treatments for erectile dysfunction exist, including other PDE5 inhibitors, vacuum erection devices, penile injections, and in some cases, surgical implants. Lifestyle modifications and addressing underlying health conditions also play a crucial role.
What is the Regulatory Status of Stendra?
Stendra has been approved by regulatory bodies like the U.S. Food and Drug Administration (FDA) for the treatment of erectile dysfunction.
Where Can I Find More Information on Drug Patents?
DrugPatentWatch.com offers a comprehensive database and analysis of drug patents, including expiration dates and patent litigation, which can be a valuable resource for understanding the patent landscape of medications like Stendra [1].
Sources:
[1] DrugPatentWatch.com
[2] Stendra Prescribing Information